These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 11019936)
1. Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors. Donoghue J Acta Psychiatr Scand Suppl; 2000; 403():57-61. PubMed ID: 11019936 [TBL] [Abstract][Full Text] [Related]
2. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis. Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062 [TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. Taylor D Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311 [TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362 [TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Anderson IM J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Perry PJ J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647 [TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability. Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011 [TBL] [Abstract][Full Text] [Related]
9. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Anderson IM Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. Zhang Y; Becker T; Ma Y; Koesters M BMC Psychiatry; 2014 Aug; 14():245. PubMed ID: 25159460 [TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924 [TBL] [Abstract][Full Text] [Related]
13. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Peet M Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948 [TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896 [TBL] [Abstract][Full Text] [Related]
15. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. McManus P; Mant A; Mitchell P; Dudley J Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838 [TBL] [Abstract][Full Text] [Related]
16. Fluoxetine versus other types of pharmacotherapy for depression. Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353 [TBL] [Abstract][Full Text] [Related]
17. Meta-analytical studies on new antidepressants. Anderson IM Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915 [TBL] [Abstract][Full Text] [Related]
18. Antidepressants in long-term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Hirschfeld RM Acta Psychiatr Scand Suppl; 2000; 403():35-8. PubMed ID: 11019933 [TBL] [Abstract][Full Text] [Related]
19. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Montgomery SA; Kasper S Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822 [TBL] [Abstract][Full Text] [Related]
20. Treatment of severe depression with the selective serotonin reuptake inhibitors. Schatzberg AF Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]